Provided by Tiger Trade Technology Pte. Ltd.

Provident

23.00
-0.4000-1.71%
Pre-market: 23.250.2472+1.07%04:04 EDT
Volume:814.76K
Turnover:18.80M
Market Cap:3.00B
PE:9.60
High:23.40
Open:23.30
Low:22.90
Close:23.40
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:1.22
T/O Rate:0.65%
Dividend:0.96
Dividend Rate:4.17%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.03
PE(LYR):10.31

Loading ...

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

GlobeNewswire
·
Jun 11

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

GlobeNewswire
·
Jun 11

New Partner Emerges for RAS Inhibitors in Treating the "King of Cancers"

Deep News
·
Jun 09

U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers

Reuters
·
Jun 09

Stephens Initiates Provident Financial Services With Equalweight Rating, $24 Price Target

MT Newswires Live
·
Jun 09

Provident Fincl Services Initiated at Equal-Weight by Stephens & Co.

Dow Jones
·
Jun 08

Provident Financial initiated with an Equal Weight at Stephens

TIPRANKS
·
Jun 08

American Battery Technology Company Wins Appeal And Has US Department Of Energy Grant Reinstated For $115 Million Project For Commercial Scale Critical Mineral Lithium Refinery

GlobeNewswire
·
Jun 08

How Broad CABOMETYX PFS Benefit At Exelixis (EXEL) Has Changed Its Investment Story

Simply Wall St.
·
Jun 07

Provident Financial Services files Form 3 for EVP, Chief Wealth Officer Annamaria Vitelli

Reuters
·
Jun 06

AKESO's New Drug Achieves Historic Milestone, Yet Market Cap Plummets by Tens of Billions

Deep News
·
Jun 05

Provident Bank Names Annamaria Vitelli Evp, Chief Wealth Officer and President of Beacon Trust

THOMSON REUTERS
·
Jun 04

Press Release: Provident Bank Names Annamaria Vitelli EVP, Chief Wealth Officer and President of Beacon Trust

Dow Jones
·
Jun 04

Groundbreaking Cancer Treatment Doubles Survival in Pancreatic Cancer, Cutting Death Risk by 60%

Deep News
·
Jun 03

Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Jun 02

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

GlobeNewswire
·
Jun 02

BriaCell Presents Positive Clinical Data at ASCO 2026

GlobeNewswire
·
Jun 01

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

GlobeNewswire
·
May 31

Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

GlobeNewswire
·
May 31

HENLIUS Shares Surge in Afternoon Trading Following Key Clinical Milestone and Upcoming Data Release

Stock News
·
May 29